Drug intelligence / Profile preview

[99mTc]Tc(CO)3-(HE)3-Ec1

Development stage
Phase 1
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[99mTc]Tc(CO)3-(HE)3-Ec1 is a radiopharmaceutical diagnostic agent designed for single-photon emission computed tomography (SPECT). It consists of a technetium-99m tricarbonyl complex conjugated to the engineered protein Ec1, which is a designed ankyrin repeat protein (DARPin). This tracer specifically targets epithelial cell adhesion molecule (EpCAM), which is overexpressed in various tumors, including lung cancer. The primary mechanism involves binding to EpCAM-expressing tumor cells, enabling non-invasive imaging of primary tumors and regional metastases. Phase I clinical studies have demonstrated its safety, tolerability, and effective tumor visualization in patients with lung cancer. Its use may facilitate patient selection for targeted immunotherapy and assessment of treatment efficacy[1][3][4].

02

Targets

EPCAM (Epithelial cell adhesion molecule)

Beyond the preview

Go deeper on [99mTc]Tc(CO)3-(HE)3-Ec1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [99mTc]Tc(CO)3-(HE)3-Ec1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call